Inactivation of myocardin and p16 during malignant transformation contributes to a differentiation defect.
Milyavsky M, Shats I, Cholostoy A, Brosh R, Buganim Y, Weisz L, Kogan I, Cohen M, Shatz M, Madar S, Kalo E, Goldfinger N, Yuan J, Ron S, MacKenzie K, Eden A, Rotter V.
Milyavsky M, et al. Among authors: rotter v.
Cancer Cell. 2007 Feb;11(2):133-46. doi: 10.1016/j.ccr.2006.11.022.
Cancer Cell. 2007.
PMID: 17292825
Free article.